DBD Stock Summary and Trading Ideas (Diebold Nixdorf | NYSE:DBD)

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment.

Diebold Nixdorf trades on the NYSE stock market under the symbol DBD.

As of June 4, 2026, DBD stock price climbed to $82.28 with 242,225 million shares trading.

DBD has a beta of 1.24, meaning it tends to be more sensitive to market movements. DBD has a correlation of 0.16 to the broad based SPY ETF.

DBD has a market cap of $2.95 billion. This is considered a Mid Cap stock.

Last quarter Diebold Nixdorf reported $892 million in Revenue and $.67 earnings per share. This beat revenue expectation by $33 million and exceeded earnings estimates by $.05.

The top ETF exchange traded funds that DBD belongs to (by Net Assets): IJR, VTI, AVUV, IWM, VXF.

DBD has outperformed the market in the last year with a price return of +67.1% while the SPY ETF gained +28.2%. However, in the short term, DBD had mixed performance relative to the market. It has underperformed in the last 3 months, returning +4.3% vs +11.5% return in SPY. But in the last 2 weeks, DBD shares have fared better than the market returning +15.2% compared to SPY +2.1%.

DBD support price is $79.28 and resistance is $83.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DBD shares will trade within this expected range on the day.